BeOne Medicines (BEIGF) Treasury Shares (2015 - 2018)

BeOne Medicines (BEIGF) has 4 years of Treasury Shares data on file, last reported at $14.1 million in Q4 2018.

• Treasury Shares for Q4 2018 came in at $14.1 million, up 859.71% year-over-year; the trailing twelve-month figure through Dec 2018 was $14.1 million (up 859.71% YoY), and the FY2018 annual result was $14.1 million, up 859.71% from the prior year.
• Treasury Shares advanced to $14.1 million in Q4 2018 per BEIGF's latest filing, from $527904.0 in the prior quarter.
• Over five years, Treasury Shares peaked at $14.1 million in Q4 2018 and troughed at $44445.0 in Q4 2015.
• A 4-year average of $3.2 million and a median of $1.2 million in 2017 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2016 and 2017: Treasury Shares soared 2318.72% in 2016, then soared 36.69% in 2017.
• A 4-year view of Treasury Shares shows it stood at $44445.0 in 2015, then soared by 2318.72% to $1.1 million in 2016, then soared by 36.69% to $1.5 million in 2017, then soared by 859.71% to $14.1 million in 2018.
• Business Quant data shows BEIGF's Treasury Shares at $14.1 million in Q4 2018, $527904.0 in Q2 2018, and $4.1 million in Q1 2018.